Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

20,705 total articles

Aurora Mobile’s Modellix Releases Beta Plugin for DeepSeek Harness, Adding Free LLM Models to the Fast-Growing Open-Source Coding Agent

Aurora Mobile’s Modellix Releases Beta Plugin for DeepSeek Harness, Adding Free LLM Models to the Fast-Growing Open-Source Coding Agent

Aurora Mobile Limited announces the beta release of dsh-modellix, a plugin integrating its Modellix.ai platform with DeepSeek Harness—an open-source AI coding agent with rapid adoption. The plugin offers developers zero-cost access to state-of-the-art large language models (LLMs) from multiple providers via a single API key, enhancing AI media gene…

Origin Agritech Establishes R&D Center in Guizhou with Biotech Unit and State-Backed Seed Joint Venture

Origin Agritech Establishes R&D Center in Guizhou with Biotech Unit and State-Backed Seed Joint Venture

Origin Agritech Ltd., a leading Chinese agricultural biotechnology company listed on NASDAQ, has established a new Southwest R&D Center in Guizhou Province, anchored by a wholly owned biotech subsidiary and a 25% owned joint venture with a state-owned seed group. The center focuses on molecular breeding, genetic transformation, and virus-free seedl…

Lightbridge Selected for U.S. Department of Energy Launch Pad INL Program to Advance Commercialization of Lightbridge Fuel™

Lightbridge Selected for U.S. Department of Energy Launch Pad INL Program to Advance Commercialization of Lightbridge Fuel™

Lightbridge Corporation announced its selection by the U.S. Department of Energy's Nuclear Energy Launch Pad program at Idaho National Laboratory to build and operate a DOE-authorized facility for producing Lead Test Assemblies of its proprietary metallic nuclear fuel. This marks a significant advancement toward commercial deployment of Lightbridge…

GDEV announces commencement of self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

GDEV announces commencement of self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

GDEV Inc., a NASDAQ-listed gaming and entertainment company, announced a cash tender offer to repurchase up to $20 million worth of its ordinary shares, approximately 1,813,236 shares, at $11.03 per share. The tender offer aims to provide liquidity to shareholders while allowing the company to manage capitalization and deliver value, with shares ac…

Apollo Funds Agree to Sell Kelvion, a Global Leader in Cooling Solutions for Data Centers and Diversified Industrials, to SLB for $4.1 billion

Apollo Funds Agree to Sell Kelvion, a Global Leader in Cooling Solutions for Data Centers and Diversified Industrials, to SLB for $4.1 billion

SLB, a global energy technology company, has agreed to acquire Kelvion, a leading manufacturer of thermal management solutions, from Apollo-managed funds for $4.1 billion including debt. The acquisition aims to strengthen SLB's data center infrastructure offerings by integrating Kelvion's advanced cooling technologies, capitalizing on growth driven…

K&R International Services Uses Descartes to Help Automate High-Volume EU Ecommerce Import Filings

K&R International Services Uses Descartes to Help Automate High-Volume EU Ecommerce Import Filings

Descartes Systems Group announced that K&R International Services is utilizing Descartes' global security filing solution to automate the processing of European Union Import Control System 2 (ICS2) filings for large volumes of ecommerce shipments transported by charter cargo carriers. The automation improves efficiency, accuracy, and compliance for…

Nova Minerals Attends Roundtable with U.S. Department of Energy

Nova Minerals Attends Roundtable with U.S. Department of Energy

Nova Minerals Corp's CEO participated in a U.S. Department of Energy roundtable to discuss progress on establishing an integrated domestic supply chain for antimony, including military-grade antimony trisulfide from the Estelle project in Alaska. Supported by a $43.4 million Department of War award, the company is advancing mining, processing, and …

Nano Labs Announces Resignation of Director

Nano Labs Announces Resignation of Director

Nano Labs Ltd, a Nasdaq-listed Web 3.0 infrastructure and crypto treasury company, announced the resignation of director Nan Hu effective August 31, 2026. The company stated the departure will not impact ongoing operations or strategic implementation. Nano Labs remains focused on advancing its strategic priorities and sustaining effective corporate…

FirstCash Upsizes and Extends Term of Unsecured Bank Credit Facility; Size of Committed Facility Increased from $700 Million to $1.1 Billion; Maturity Date Extended to August 2031

FirstCash Upsizes and Extends Term of Unsecured Bank Credit Facility; Size of Committed Facility Increased from $700 Million to $1.1 Billion; Maturity Date Extended to August 2031

FirstCash Holdings, Inc. has amended its unsecured revolving credit facility, increasing the committed amount from $700 million to $1.055 billion and extending the maturity from August 2029 to August 2031. The amendment also includes increased leverage capacity and flexibility in borrowing currencies. This extended facility supports FirstCash's gro…

Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations

Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations

Alvotech announced that the U.S. FDA has accepted for review its Biologics License Application (BLA) for AVT80, a proposed interchangeable biosimilar to Entyvio delivered via prefilled syringe and autoinjector for subcutaneous administration. This complements AVT16, the intravenous biosimilar whose BLA was accepted in May 2026. Under a partnership …

WEBUY GLOBAL LTD. Reports Record NATAS Fair Bookings of US$ 4.76 Million, 42% Higher than March 2026

WEBUY GLOBAL LTD. Reports Record NATAS Fair Bookings of US$ 4.76 Million, 42% Higher than March 2026

WEBUY GLOBAL LTD. announced record preliminary unaudited travel bookings totaling approximately US$4.76 million during the three-day NATAS Fair in August 2026, marking a 42% increase from the previous fair in March 2026. Growth was driven by strong demand in both mainstream and premium travel offerings, supported by AI-assisted sales tools and stra…

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM

BridgeBio Pharma announced compelling new data from the Phase 3 ATTRibute-CM study highlighting Acoramidis' ability to potentially reverse cardiac structural disease progression and functional decline in transthyretin amyloid cardiomyopathy (ATTR-CM). Treated patients experienced significant improvements in left ventricular function and substantial…

Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026

Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026

Cytokinetics announced additional positive results from two Phase 3 clinical trials, ACACIA-HCM and MAPLE-HCM, demonstrating that their drug aficamten improved cardiac function and symptoms in patients with non-obstructive and obstructive hypertrophic cardiomyopathy (HCM). Notably, ACACIA-HCM showed aficamten improved cardiac structure and diastoli…

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026

Tenax Therapeutics announced additional data from its Phase 3 LEVEL trial evaluating oral levosimendan (TNX-103) in patients with pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). While primary endpoints on exercise capacity were not met, subgroup analysis revealed significant improvements in patients with low…

20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity

20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity

20/20 BioLabs announced a rescheduled investor webinar to discuss its second quarter 2026 performance, highlighting record revenue growth from its multi-cancer early detection test, OneTest™. CEO Jonathan Cohen will detail the company's evolving test platform, successful state-funded cancer screening initiatives, and the strategic path toward regul…

AiRWA receives expected notification of deficiency from Nasdaq related to delayed filing of annual report on Form 10-K

AiRWA receives expected notification of deficiency from Nasdaq related to delayed filing of annual report on Form 10-K

AiRWA Inc. announced receiving a deficiency notice from Nasdaq owing to its failure to timely file the annual Form 10-K report for the fiscal year ended April 30, 2026. The delay is attributed to challenges in consolidating financials after a significant acquisition. The company has until October 23, 2026, to submit a compliance plan and expects to…